Bryan J. Barratt

AstraZeneca R&D
Alderley Park, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.

Meta-analysis of genome-wide association studies of HDL cholesterol response to statins.

Journal: Journal of medical genetics

Published: April 18, 2016

Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome.

Genome-wide association and Mendelian randomization study of NT-proBNP in patients with acute coronary syndrome.

Journal: Human molecular genetics

Published: October 22, 2015

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes.

Journal: European heart journal

Published: November 21, 2014

Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures.

Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein-Related Measures.

Journal: Circulation. Cardiovascular genetics

Published: November 18, 2014

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).

NLRC4 Inflammasome Is an Important Regulator of Interleukin-18 Levels in Patients With Acute Coronary Syndromes: Genome-Wide Association Study in the PLATelet inhibition and patient Outcomes Trial (PLATO).

Journal: Circulation. Cardiovascular genetics

Published: June 02, 2014

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins.

Journal: Nature communications

Published: February 27, 2014

Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study.

Polymorphism of the cystatin C gene in patients with acute coronary syndromes: Results from the PLATelet inhibition and patient Outcomes study.

Journal: American heart journal

Published: December 29, 2013

Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.

Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy.

Journal: Circulation. Cardiovascular genetics

Published: November 03, 2012

Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy.

Lack of association between SLCO1B1 polymorphisms and clinical myalgia following rosuvastatin therapy.

Journal: American heart journal

Published: September 26, 2012

Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial.

Journal: Circulation. Cardiovascular genetics

Published: February 15, 2012

Pharmacogenetic determinants of statin-induced reductions in C-reactive protein.

Pharmacogenetic determinants of statin-induced reductions in C-reactive protein.

Journal: Circulation. Cardiovascular genetics

Published: January 11, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026